ライフサイエンスコーパス: diagnostics

1 ong others, to aid mechanistic discovery and diagnostics.

2 through stool samples submitted for clinical diagnostics.

3 extends beyond the basics of IFI laboratory diagnostics.

4 nd non-invasive method for universal medical diagnostics.

5 with microfluidic devices for point-of-care diagnostics.

6 ed a new era of nucleic acid-based molecular diagnostics.

7 vent of antiretroviral therapy and molecular diagnostics.

8 ion would catalyze a revolution in molecular diagnostics.

9 sensing near these limits, e.g. for medical diagnostics.

10 mens are the reference standard for COVID-19 diagnostics.

11 athophysiology and biomarker development for diagnostics.

12 d three isotype-specific assays for in-depth diagnostics.

13 is the gold standard specimen for pneumonia diagnostics.

14 nning from genomics to antisense therapy and diagnostics.

15 affinity ligands for TSPO-based therapies or diagnostics.

16 tacles of utilizing the method for universal diagnostics.

17 ing photonics, chemical sensing, and medical diagnostics.

18 biological circuit components and precision diagnostics.

19 retable results for phenotype-driven genomic diagnostics.

20 ng and analyzing long-term data for reliable diagnostics.

21 enrichment and stratification, and precision diagnostics.

22 s the most informative approach for clinical diagnostics.

23 hese assays is limiting their use in routine diagnostics.

24 ica, demands immediate attention for bedside diagnostics.

25 extend the importance of NGAL in AKI beyond diagnostics.

26 ing groups, and standardization of molecular diagnostics.

27 sifed by infections detectable using routine diagnostics.

28 e development of glycoconjugate vaccines and diagnostics.

29 ystems, and MI in context with comprehensive diagnostics.

30 ples, with potential applications in medical diagnostics.

31 ations in drug delivery, medical devices and diagnostics.

32 aving precious time in bloodstream infection diagnostics.

33 s of disease progression and improve medical diagnostics.

34 graphy (CT; AUC = 0.80) obtained for routine diagnostics.

35 examination training and home-based patient diagnostics.

36 stance and the development of genotype-based diagnostics.

37 with many potential applications in medical diagnostics.

38 of impedance and more sensitive oversensing diagnostics.

39 with real-time PCR systems required for qPCR diagnostics.

40 ratories, blood banks, and for point-of-care diagnostics.

41 ualized phage therapy, biocontrol, and rapid diagnostics.

42 equires rapid, cheap, scalable, and accurate diagnostics.

43 old standard in both imprinting research and diagnostics.

44 s the potential to transform prostate cancer diagnostics.

45 s related to the use of SARS-CoV-2 molecular diagnostics.

46 of the future scope of research in QCM-based diagnostics.

47 ormance indicators required in point-of-care diagnostics.

48 et for vaccines, therapeutic antibodies, and diagnostics.

49 role of non-obstructive CAD patients in CAD diagnostics.

50 mplementation of exome sequencing in routine diagnostics.

51 uctures are highly beneficial for healthcare diagnostics.

52 ns in industry, material science and medical diagnostics.

53 aging spectroscopy in coronal magnetic field diagnostics.

54 ms for development of new generations of MRI diagnostics.

55 egrated device as a tool for prognostics and diagnostics.

56 have shown potential in noninvasive prenatal diagnostics.

57 atform with great potential in point-of-care diagnostics.

58 of visual and electronic readouts for use in diagnostics.

59 , sports performance monitoring, and medical diagnostics.

60 antibodies remains a cornerstone of clinical diagnostics.

61 t of next-generation point-of-care molecular diagnostics.

62 biofluids, essential for rapid point-of-care diagnostics.

63 eted delivery of NANP-based therapeutics and diagnostics.

64 )-cleared platform otherwise used for cancer diagnostics.

65 130 nGy(air) s(-1), both desired in medical diagnostics.

66 r COVID-19 prevention, patient treatment and diagnostics.

67 This GFAP level is compatible with clinical diagnostics.

68 ntibiotic resistance assessment, and medical diagnostics.

69 c detection with potential use in real-world diagnostics.

70 high throughput opportunities for molecular diagnostics.

71 romising application potential in biomedical diagnostics.

72 ional connections" for maps and neurological diagnostics.

73 Serology is essential for Q fever diagnostics, a disease caused by the bacterial pathogen

74 in the development of these 'activity-based diagnostics' (ABDx) and their application in infectious

75 rdship program (ASP) intervention, and rapid diagnostics (ADX in addition to conventional standard) w

76 r analysis will have a significant impact in diagnostics after renal transplantation.

77 n the development of accessible and reliable diagnostics allowing correct prediction of the clinical

78 ith a broad range of applications in medical diagnostics and analytical chemistry.

79 ntibodies and their utility both as clinical diagnostics and as research tools to evaluate the effect

80 biomarkers plays important roles in clinical diagnostics and biomedical research.

81 hen conducted, should utilize more sensitive diagnostics and clear context-specific operational param

82 sts between availability of state-of-the-art diagnostics and current needs.

83 ake potentially significant contributions to diagnostics and derived personalized healthcare.

84 Despite significant progress in diagnostics and disease management during the past decad

85 ting microfluidic chips (lab-on-a-paper) for diagnostics and drug delivery for biomedical application

86 ng with cell culturing in relation to, e.g., diagnostics and drug screening.

87 se results emphasize the potential for rapid diagnostics and early optimization of treatment to impac

88 A universal SP test would simplify frontline diagnostics and facilitate large-scale serological surve

89 r numerous applications ranging from medical diagnostics and food safety inspection, to environmental

90 de of care for hepatitis C with cost data on diagnostics and hepatitis C treatment.

91 ing provides new opportunities for molecular diagnostics and image-guided biomedical applications.

92 s in allergen and epitope discovery, allergy diagnostics and immunotherapy.

93 ations in the field of non-invasive clinical diagnostics and in-situ environmental monitoring.

94 pectives to be exploited in the multipurpose diagnostics and it can be used as a pre-screening tool i

95 s to increasing complexity and high cost for diagnostics and limits their wide accessibility in low-r

96 Few studies exist regarding diagnostics and management of burn wounds in veterinary

97 rious diseases with well-known biomarkers in diagnostics and monitoring, especially with potential fu

98 ioritize variants for inclusion into routine diagnostics and patient management.

99 ology as well as to the development of early diagnostics and personalized therapies.

100 of oncometabolites and their utilization in diagnostics and prognostics, as novel therapeutic target

101 as a biomarker signature for prostate cancer diagnostics and prognostics.

102 ntomics is an emerging area in cell-free DNA diagnostics and research.

103 lications from single-molecule biosensing to diagnostics and sequencing.

104 virus, which has implications for molecular diagnostics and the design of potential vaccines.

105 monitoring become crucial to allow specific diagnostics and the effective monitoring of the associat

106 zable framework to design conditional cancer diagnostics and therapeutics and showcased in the Hi-Myc

107 nd accelerate the development of conditional diagnostics and therapeutics for multiple cancer types.

108 The renaissance of complement diagnostics and therapeutics has introduced precision me

109 een the emergence of conditionally activated diagnostics and therapeutics that leverage protease-clea

110 Better understanding of complement diagnostics and therapeutics will not only facilitate ph

111 olecule secretion to outperform conventional diagnostics and therapeutics, thereby facilitating their

112 Over the past decade, despite novel diagnostics and therapeutics, together with changes in t

113 cancer and guides the design of conditional diagnostics and therapeutics.

114 lity of DNA-functionalized nanostructures in diagnostics and therapeutics.

115 hysiological signals for self-powered health diagnostics and therapeutics.

116 gy of the adaptive immune system and empower diagnostics and therapeutics.

117 as the potential to revolutionize biological diagnostics and therapeutics; however, broad adoption is

118 options to integrate nanoparticles into both diagnostics and therapy for both grafts ex-situ before t

119 ough phenotypic similarity, for differential diagnostics and to facilitate translational research.

120 iosensors has the potential to contribute to diagnostics and to revolutionise the field of microbial

121 Improved tuberculosis diagnostics and tools for monitoring treatment response

122 t for implementation of DNAm signatures into diagnostics and translational research.

123 f great significance for improved healthcare diagnostics and treatment in the future, for which a wea

124 microbiomes impact on cancers can yield new diagnostics and treatments, but much remains unknown.

125 further application in sequencing, clinical diagnostics and ultra-sensitive single molecule detectio

126 will provide insights towards the design of diagnostics and vaccine candidates against this high pri

127 g at the single-cell level, advanced medical diagnostics, and analytical detection of biomolecules an

128 The research in biomedicine, cell signaling, diagnostics, and biocatalysis rely on selective protein

129 esence of alarming signs), use and result of diagnostics, and focus and cause of infection.

130 ypeptide conjugates to advance therapeutics, diagnostics, and fundamental science.

131 ne solution for C. difficile infection (CDI) diagnostics, and further prospective clinical studies ar

132 ocess involved in cellular behavior, medical diagnostics, and material fabrication.

133 l to identify novel pathophysiology, improve diagnostics, and monitor disease through noninvasive mic

134 current state of osteomyelitis epidemiology, diagnostics, and therapeutic guidelines to help direct f

135 ossible applications in complement research, diagnostics, and therapeutics.

136 w that PRSs were associated with SCZ and MDD diagnostics, and with cognition in SCZ and pathology in

137 Sensitive point-of-care diagnostics are also lacking for nonfalciparum malaria,

138 Until better diagnostics are available to accurately differentiate be

139 o produce a sputum specimen, and traditional diagnostics are costly or unavailable.

140 Given scarce resources, nonlaboratory diagnostics are crucial.

141 Rapid, inexpensive, robust diagnostics are essential to control the spread of infec

142 Current state of the art diagnostics are highly sensitive and specific, but slow,

143 opments are encouraging, all current typhoid diagnostics are inadequate, having either poor performan

144 metastatic prostate cancer (mPC), molecular diagnostics are increasingly used.

145 h prevalences close to zero, highly specific diagnostics are necessary.

146 duals detected exclusively by ultrasensitive diagnostics are negligible for human-to-mosquito transmi

147 Simplified diagnostics are required for low-resource settings and d

148 Rapid, affordable, and accurate diagnostics are urgently needed, particularly in setting

149 at using A9 as a probe for molecular imaging diagnostics as well as active targeting of anticancer dr

150 capability for molecular typing and clinical diagnostics, as well as facilitate the accurate identifi

151 nventional diagnostics, n = 64; conventional diagnostics + ASP, n = 68; rapid diagnostics + ASP; n =

152 onventional diagnostics + ASP, n = 68; rapid diagnostics + ASP; n = 72) were evaluated.

153 so opens new avenues for precision medicine- diagnostics (assement of risk) as well as early treatmen

154 d electronic states and sensing elements for diagnostics at interfaces.

155 g the viral and bacterial enteric panels (BD Diagnostics, Baltimore, MD, USA).

156 es hold particular promise for liquid biopsy diagnostics but are currently limited by the lack of rob

157 ng (MRI) is essential for multiple sclerosis diagnostics but is conventionally not specific to demyel

158 -resistant organisms is facilitated by rapid diagnostics, but rare resistance mechanisms can compromi

159 ltiplex RT-qPCR improves upon current single diagnostics by saving reagents, costs, time, and labor.

160 tting edge biochemical techniques, including diagnostics, by making portable and electricity-free hea

161 CRISPR diagnostics can augment gold-standard PCR-based testing

162 f-care (POC) device to enable de-centralized diagnostics can effectively reduce the time to treatment

163 old promise for bringing RCA-based molecular diagnostics closer to the point-of-care.

164 forces the viewpoint that diphtheria culture diagnostics continue to provide the most accurate case c

165 re limited therapeutics and patient-specific diagnostics currently available.

166 by state was conducted, utilizing the Quest Diagnostics database.

167 er and promising target for therapeutics and diagnostics directed at age-related macular degeneration

168 Our results suggest that cheaper diagnostics do not necessarily translate to less costly

169 help to accelerate the development of novel diagnostics, drugs and vaccines to stop the COVID-19 dis

170 Phosphoprotein IHC have been impractical for diagnostics due to inconsistent results occurring from t

171 pathogens in food and water safety, medical diagnostics, environmental monitoring, and bio-threat ap

172 s analytical applications, including medical diagnostics, environmental monitoring, and drug detectio

173 earch discussed at the conference, including diagnostics, environmental surveillance, drug resistance

174 during diarrhea using quantitative molecular diagnostics for 29 pathogens.

175 Genotype-based diagnostics for antibiotic resistance represent a promis

176 a promising platform for rapid point-of-care diagnostics for citrus farmers and small nurseries in lo

177 s developing antibody-based therapeutics and diagnostics for CoV-2.

178 need for low-cost but reliable point-of-care diagnostics for early screening of infections especially

179 need in clinical point-of-care (POC) cancer diagnostics for early state disease detection, which wou

180 eted metabolomics (GUM) has entered clinical diagnostics for genetic disorders.

181 w great utility for the development of rapid diagnostics for infectious diseases because they have hi

182 malaria eradication requires ultrasensitive diagnostics for low parasite density infections (<100 pa

183 lable to investigators developing laboratory diagnostics for Lyme disease.

184 Finally, improved criteria and diagnostics for neurosyphilis (as well as ocular and oti

185 ew imaging methods are required as companion diagnostics for optimizing immunotherapies.

186 safe and effective vaccines, therapies, and diagnostics for SARS- coronavirus 2 (CoV-2), the develop

187 the development of vaccines and serological diagnostics for severe acute respiratory syndrome corona

188 nces for successful treatment, but available diagnostics for some tumours, including lung adenocarcin

189 ns and motivates the development of improved diagnostics for the detection of colistin-resistant orga

190 This approach provides critical diagnostics for the temporal coherence of x-ray FELs and

191 ant for many applications including clinical diagnostics, functional proteomics, and drug discovery.

192 e nucleic acids in body fluids enables early diagnostics, genotyping and personalized therapy, but is

193 d outcomes for rapid intervention with rapid diagnostics have been documented and include decreased m

194 Most recently, molecular diagnostics have played an essential role in the global

195 y changes in clinician behavior and improved diagnostics, have the opportunity to broadly reduce anti

196 The advanced diagnostics help to understand the interaction between t

197 rch teams and their application in PCR-based diagnostics, high-affinity DNA aptamer generation, site-

198 Combining conventional diagnostics (histology, serology, and clinical data) and

199 ss the need for better screening and medical diagnostics in all areas of disease.

200 innovative approaches to facilitate clinical diagnostics in an elusive group of diseases.

201 or early detection, prognosis, and companion diagnostics in breast cancer.

202 a new diagnostic test developed in the Rapid Diagnostics in Categorizing Acute Lung Infections (RADIC

203 ded tissue specimens collected for pathology diagnostics in Central Africa between 1958 and 1966.

204 again need to reconsider the role of typhoid diagnostics in how they can aid in facilitating disease

205 IV-positive inpatients with sputum and urine diagnostics in Malawi and South Africa (Rapid urine-base

206 8)Ga-PSMA-guided bone biopsies for molecular diagnostics in mPC patients.

207 tive smartphone-based point-of-care pathogen diagnostics in resource-limited settings.

208 ors offer the prospect for on-demand sensing diagnostics in simple and low-cost form factors, enablin

209 strates the importance of broad differential diagnostics in the context of liver abscesses.

210 ent can maintain the fidelity of video-based diagnostics in the face of missing values and variable v

211 bott Laboratories (Abbott Park, IL), Epitope Diagnostics, Inc.

212 y that are amenable to the development of AI diagnostics include genomic information from isolated ba

213 Integrating precision diagnostics into personalized treatments requires unders

214 veillance; and third, to integrate companion diagnostics into randomized clinical trials to enable pr

215 DNA methylation data-based precision cancer diagnostics is emerging as the state of the art for mole

216 Accurate, rapid, and low-cost molecular diagnostics is essential in managing outbreaks of infect

217 ven that the overall success rate of genomic diagnostics is only around 25%-50% or less in many cohor

218 vity (e.g., single-cell sequencing, pathogen diagnostics) it is desirable to use low dilutions (e.g.,

219 has considerable potential to reshape the TB diagnostics landscape, making diagnosis and treatment in

220 Novel handheld quantitative G6PD diagnostics may allow greater standardisation in the fut

221 t this background, rapid culture-independent diagnostics may allow targeted treatment and prevent onw

222 e Fagales tree homologous group, but further diagnostics may be needed for some patients to determine

223 linical awareness and access to simple rapid diagnostics may improve the diagnosis of blastomycosis i

224 ing hydraulic damage and carbon assimilation diagnostics, moderately improve mortality prediction acr

225 Two hundred four patients (conventional diagnostics, n = 64; conventional diagnostics + ASP, n =

226 Although also used for imaging and diagnostics, nanoparticles' utility as a drug or genetic

227 is now becoming a real possibility, but new diagnostics need to be part of the equation and factored

228 osensor for rapid, cost-effective, selective diagnostics of a targeted disease for health care manage

229 tiplex label-free biosensor is developed for diagnostics of autoimmune diseases by highly sensitive m

230 ed to develop new criteria for comprehensive diagnostics of autoimmune diseases, based not only on tr

231 ir capacity to provide rapid and inexpensive diagnostics of cancer and infectious diseases.

232 te that RS is capable of much more sensitive diagnostics of HLB compared to qPCR.

233 Laboratory diagnostics of infected patients, and the assessment of

234 In diagnostics of infectious diseases, matrix-assisted lase

235 ndicate that qAF may facilitate differential diagnostics of MD/CCRDs and may offer novel pathogenetic

236 tational analysis, mechanistic discovery and diagnostics of Mendelian diseases.

237 ring the results of the sensor with clinical diagnostics of more than 140 normal and involved cases r

238 of the art minimally invasive treatments and diagnostics of neurological and cardiovascular diseases

239 Diagnostics of PC1 indicate previous year's local Air Te

240 monitoring of the analgesic as well as quick diagnostics of possible overdose in emergency care.

241 sed analysis has become standard for genomic diagnostics of rare diseases.

242 Thus, clinical RNA-Seq extends molecular diagnostics of rare genodermatoses, and it could provide

243 s still regarded as the gold standard in the diagnostics of transplant renal artery stenosis (TRAS).

244 rate a Lab-on-paper for all-in-one molecular diagnostics of zika, dengue, and chikungunya virus from

245 ally, RS can be used for Huanglongbing (HLB) diagnostics on both orange and grapefruit trees, as well

246 a suitable specimen type for enteropathogen diagnostics on the BD Max system.

247 y in risk stratification, early recognition, diagnostics, precision medicine, and other interventiona

248 m three broad areas of biomedicine: clinical diagnostics, precision treatments, and health monitoring

249 Diagnostics presented in this work can be applied to stu

250 virus pathogenicity and possible targets for diagnostics, prognostication, and interventions.

251 supplement address key questions on syphilis diagnostics, provide reference tables of test performanc

252 Molecular diagnostics provided a supportive microbiological diagno

253 scored on a 5-point scale, first in routine diagnostics (reader 1) and then by an independent second

254 Together with recent innovations in diagnostics, remote rhythm monitoring, and big data capa

255 oimmun (Lubeck, Germany), and Ortho-Clinical Diagnostics (Rochester, NY), using a panel of serially c

256 ment of critical tools, including innovative diagnostics, safe and effective vaccines, and new and im

257 eningitis/Encephalitis panel (FA-ME; BioFire Diagnostics, Salt Lake City, UT), we aimed to determine

258 ic nature of symptoms; therefore, laboratory diagnostics should be utilized for patients with residen

259 osensors are powerful tools in point-of-care diagnostics since they are affordable, portable, user-fr

260 In disease diagnostics, single- and multiplex nucleic acid (NA) det

261 lactate sensors are widely used for clinical diagnostics, sports medicine, and food quality control.

262 The use of molecular diagnostics, such as reverse transcription PCR or unbias

263 tic use and discharge prescribing rates when diagnostics suggested viral respiratory tract infection,

264 may help with comprehensive noninvasive CAD diagnostics.Supplemental material is available for this

265 The development of new diagnostics techniques and modalities is critical for ea

266 In particular, point-of-care diagnostics that are able to reduce and/or prevent unnee

267 This is crucial for the initial diagnostics that are necessary to establish a diagnosis

268 However, culture-based diagnostics that are time-consuming remain the gold stan

269 te drug treatment strategies are informed by diagnostics that establish the prevalence and intensity

270 tools are converging to guide the design of diagnostics that leverage enzymatic activity to measure

271 to produce a diagnostic readout, as well as diagnostics that use enzymes as an engineered component

272 lf-assembly for fields including biophysics, diagnostics, therapeutics, photonics, and nanofabricatio

273 re fundamental analytical tools in molecular diagnostics, therapy monitoring and drug discovery.

274 e been broadly studied in different areas of diagnostics, they are not yet fully commercialized.

275 TRAPs, which remain hidden to prior flow diagnostics, thus provide critical information for hazar

276 t advances in optical coding, drug delivery, diagnostics, tissue engineering, shear-induced gelation,

277 Diagnostics to accurately detect disease and monitor the

278 s encourage further development of molecular diagnostics to be used with whole blood for detection of

279 There is a need for rapid and accurate diagnostics to better monitor and prevent the spread of

280 e made to collect robust data using improved diagnostics to better understand geographical heterogene

281 e studies across the spectrum of image-based diagnostics to improve human-computer collaboration in c

282 ge transcriptionally upon stress exposure as diagnostics to predict antibiotic sensitivity.

283 cs may necessitate waiting for culture-based diagnostics to select an effective treatment.

284 on required to develop a LC-based analytical diagnostics tool are also the focus of this report.

285 IMI and highlights the potential benefit of diagnostics tools to identify S. aureus CC during bovine

286 Identification of these signals could aid in diagnostics, treatment decision-making, and risk evaluat

287 arkers of RSV disease severity would benefit diagnostics, treatment decisions, and prophylactic inter

288 sies provide unique opportunities for cancer diagnostics, treatment selection, and response monitorin

289 rk highlights the potential for health state diagnostics using all metabolomics features with data-dr

290 e well-calibrated CP estimates for precision diagnostics using DNA methylation data.

291 ncing primers, CRISPR guides (from research, diagnostics, vaccines, and therapies), and points of int

292 This is particularly relevant for medical diagnostics, where assay turn-around-time can have an im

293 clude by highlighting the future of COVID-19 diagnostics, which include the need for quantitative tes

294 dditional capacity to address the backlog of diagnostics will minimise deaths as a result of diagnost

295 Maintenance of these diagnostics will therefore require surveillance to ensur

296 gration of ADX: conventional microbiological diagnostics with and without antimicrobial stewardship p

297 More recently, a newer generation of diagnostics with immense potential has emerged, includin

298 , specificity and flexibility of established diagnostics with the ease, cost effectiveness and speed

299 damage to brain tissue could yield molecular diagnostics with the potential to improve how we detect

300 cant cell populations is essential in modern diagnostics, yet existing methods are often limited and